Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - DEFERRED INCOME TAX
Deferred Income Tax HALO - Halozyme Therapeutics, Inc.
532 K
LAST VALUE
-88.47%
2 YEAR CAGR
1.66%
5 YEAR CAGR
-10.92%
10 YEAR CAGR